Belinda Kweka1, Eric Lyimo1, Kidola Jeremiah1, Suzanne Filteau2, Andrea M Rehman2, Henrik Friis3, Alphaxard Manjurano1, Daniel Faurholt-Jepsen4, Rikke Krogh-Madsen5, George PrayGod1, Douglas C Heimburger6. 1. Mwanza Research Centre, National Institute for Medical Research, Mwanza, Tanzania. 2. Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, United Kingdom. 3. Department of Nutrition, Exercise, and Sports, University of Copenhagen, Copenhagen, Denmark. 4. Department of Infectious Diseases, Rigshospitalet, Denmark. 5. Centre for Physical Activity Research, Rigshospitalet, University of Copenhagen, Denmark. 6. Vanderbilt Institute for Global Health and Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States of America.
Abstract
INTRODUCTION: Hemoglobin A1c (HbA1c) is recommended for diagnosing and monitoring diabetes. However, in people with sickle cell disease (SCD), sickle cell trait (SCT), α-thalassemia or glucose-6-phosphate dehydrogenase (G6PD) deficiency, HbA1c may underestimate the prevalence of diabetes. There are no data on the extent of this problem in sub-Saharan Africa despite having high prevalence of these red blood cell disorders. METHODS: Blood samples from 431 adults in northwestern Tanzania, randomly selected from the prospective cohort study, Chronic Infections, Comorbidities and Diabetes in Africa (CICADA), were analysed for SCT/SCD, α-thalassemia and G6PD deficiency and tested for associations with the combined prevalence of prediabetes and diabetes (PD/DM) by HbA1c, using the HemoCue 501 HbA1c instrument, and by 2-hour oral glucose tolerance test (OGTT). RESULTS: The mean age of the participants was 40.5 (SD11.6) years; 61% were females and 71% were HIV-infected. Among 431 participants, 110 (25.5%) had SCT and none had SCD. Heterozygous α-thalassemia (heterozygous α+ AT) was present in 186 (43%) of the participants, while 52 participants (12%) had homozygous α-thalassemia (homozygous α+ AT). Furthermore, 40 (9.3%) participants, all females, had heterozygous G6PD deficiency while 24 (5.6%) males and 4 (0.9%) females had hemizygous and homozygous G6PD deficiency, respectively. In adjusted analysis, participants with SCT were 85% less likely to be diagnosed with PD/DM by HbA1c compared to those without SCT (OR = 0.15, 95% CI: 0.08, 0.26, P < 0.001). When using OGTT, in adjusted analysis, SCT was not associated with diagnosis of PD/DM while participants with homozygous α+ AT and hemizygous G6PD deficiency were more likely to be diagnosed with PD/DM. CONCLUSIONS: HbA1c underestimates the prevalence of PD/DM among Tanzanian adults with SCT. Further research using other HbA1c instruments is needed to optimize HbA1c use among populations with high prevalence of hemoglobinopathies or G6PD deficiency.
INTRODUCTION: Hemoglobin A1c (HbA1c) is recommended for diagnosing and monitoring diabetes. However, in people with sickle cell disease (SCD), sickle cell trait (SCT), α-thalassemia or glucose-6-phosphate dehydrogenase (G6PD) deficiency, HbA1c may underestimate the prevalence of diabetes. There are no data on the extent of this problem in sub-Saharan Africa despite having high prevalence of these red blood cell disorders. METHODS: Blood samples from 431 adults in northwestern Tanzania, randomly selected from the prospective cohort study, Chronic Infections, Comorbidities and Diabetes in Africa (CICADA), were analysed for SCT/SCD, α-thalassemia and G6PD deficiency and tested for associations with the combined prevalence of prediabetes and diabetes (PD/DM) by HbA1c, using the HemoCue 501 HbA1c instrument, and by 2-hour oral glucose tolerance test (OGTT). RESULTS: The mean age of the participants was 40.5 (SD11.6) years; 61% were females and 71% were HIV-infected. Among 431 participants, 110 (25.5%) had SCT and none had SCD. Heterozygous α-thalassemia (heterozygous α+ AT) was present in 186 (43%) of the participants, while 52 participants (12%) had homozygous α-thalassemia (homozygous α+ AT). Furthermore, 40 (9.3%) participants, all females, had heterozygous G6PD deficiency while 24 (5.6%) males and 4 (0.9%) females had hemizygous and homozygous G6PD deficiency, respectively. In adjusted analysis, participants with SCT were 85% less likely to be diagnosed with PD/DM by HbA1c compared to those without SCT (OR = 0.15, 95% CI: 0.08, 0.26, P < 0.001). When using OGTT, in adjusted analysis, SCT was not associated with diagnosis of PD/DM while participants with homozygous α+ AT and hemizygous G6PD deficiency were more likely to be diagnosed with PD/DM. CONCLUSIONS: HbA1c underestimates the prevalence of PD/DM among Tanzanian adults with SCT. Further research using other HbA1c instruments is needed to optimize HbA1c use among populations with high prevalence of hemoglobinopathies or G6PD deficiency.
Authors: D Modiano; G Luoni; B S Sirima; J Simporé; F Verra; A Konaté; E Rastrelli; A Olivieri; C Calissano; G M Paganotti; L D'Urbano; I Sanou; A Sawadogo; G Modiano; M Coluzzi Journal: Nature Date: 2001-11-15 Impact factor: 49.962
Authors: Mary E Lacy; Gregory A Wellenius; Anne E Sumner; Adolfo Correa; Mercedes R Carnethon; Robert I Liem; James G Wilson; David B Sacks; David R Jacobs; April P Carson; Xi Luo; Annie Gjelsvik; Alexander P Reiner; Rakhi P Naik; Simin Liu; Solomon K Musani; Charles B Eaton; Wen-Chih Wu Journal: JAMA Date: 2017-02-07 Impact factor: 157.335
Authors: Materko Wollner; Benchimol-Barbosa Paulo Roberto; Silva Carvalho Alysson Roncally; Nadal Jurandir; Luis Santos Edil Journal: J Public Health Res Date: 2017-09-21
Authors: Eleanor Wheeler; Aaron Leong; Ching-Ti Liu; Marie-France Hivert; Rona J Strawbridge; Clara Podmore; Man Li; Jie Yao; Xueling Sim; Jaeyoung Hong; Audrey Y Chu; Weihua Zhang; Xu Wang; Peng Chen; Nisa M Maruthur; Bianca C Porneala; Stephen J Sharp; Yucheng Jia; Edmond K Kabagambe; Li-Ching Chang; Wei-Min Chen; Cathy E Elks; Daniel S Evans; Qiao Fan; Franco Giulianini; Min Jin Go; Jouke-Jan Hottenga; Yao Hu; Anne U Jackson; Stavroula Kanoni; Young Jin Kim; Marcus E Kleber; Claes Ladenvall; Cecile Lecoeur; Sing-Hui Lim; Yingchang Lu; Anubha Mahajan; Carola Marzi; Mike A Nalls; Pau Navarro; Ilja M Nolte; Lynda M Rose; Denis V Rybin; Serena Sanna; Yuan Shi; Daniel O Stram; Fumihiko Takeuchi; Shu Pei Tan; Peter J van der Most; Jana V Van Vliet-Ostaptchouk; Andrew Wong; Loic Yengo; Wanting Zhao; Anuj Goel; Maria Teresa Martinez Larrad; Dörte Radke; Perttu Salo; Toshiko Tanaka; Erik P A van Iperen; Goncalo Abecasis; Saima Afaq; Behrooz Z Alizadeh; Alain G Bertoni; Amelie Bonnefond; Yvonne Böttcher; Erwin P Bottinger; Harry Campbell; Olga D Carlson; Chien-Hsiun Chen; Yoon Shin Cho; W Timothy Garvey; Christian Gieger; Mark O Goodarzi; Harald Grallert; Anders Hamsten; Catharina A Hartman; Christian Herder; Chao Agnes Hsiung; Jie Huang; Michiya Igase; Masato Isono; Tomohiro Katsuya; Chiea-Chuen Khor; Wieland Kiess; Katsuhiko Kohara; Peter Kovacs; Juyoung Lee; Wen-Jane Lee; Benjamin Lehne; Huaixing Li; Jianjun Liu; Stephane Lobbens; Jian'an Luan; Valeriya Lyssenko; Thomas Meitinger; Tetsuro Miki; Iva Miljkovic; Sanghoon Moon; Antonella Mulas; Gabriele Müller; Martina Müller-Nurasyid; Ramaiah Nagaraja; Matthias Nauck; James S Pankow; Ozren Polasek; Inga Prokopenko; Paula S Ramos; Laura Rasmussen-Torvik; Wolfgang Rathmann; Stephen S Rich; Neil R Robertson; Michael Roden; Ronan Roussel; Igor Rudan; Robert A Scott; William R Scott; Bengt Sennblad; David S Siscovick; Konstantin Strauch; Liang Sun; Morris Swertz; Salman M Tajuddin; Kent D Taylor; Yik-Ying Teo; Yih Chung Tham; Anke Tönjes; Nicholas J Wareham; Gonneke Willemsen; Tom Wilsgaard; Aroon D Hingorani; Josephine Egan; Luigi Ferrucci; G Kees Hovingh; Antti Jula; Mika Kivimaki; Meena Kumari; Inger Njølstad; Colin N A Palmer; Manuel Serrano Ríos; Michael Stumvoll; Hugh Watkins; Tin Aung; Matthias Blüher; Michael Boehnke; Dorret I Boomsma; Stefan R Bornstein; John C Chambers; Daniel I Chasman; Yii-Der Ida Chen; Yduan-Tsong Chen; Ching-Yu Cheng; Francesco Cucca; Eco J C de Geus; Panos Deloukas; Michele K Evans; Myriam Fornage; Yechiel Friedlander; Philippe Froguel; Leif Groop; Myron D Gross; Tamara B Harris; Caroline Hayward; Chew-Kiat Heng; Erik Ingelsson; Norihiro Kato; Bong-Jo Kim; Woon-Puay Koh; Jaspal S Kooner; Antje Körner; Diana Kuh; Johanna Kuusisto; Markku Laakso; Xu Lin; Yongmei Liu; Ruth J F Loos; Patrik K E Magnusson; Winfried März; Mark I McCarthy; Albertine J Oldehinkel; Ken K Ong; Nancy L Pedersen; Mark A Pereira; Annette Peters; Paul M Ridker; Charumathi Sabanayagam; Michele Sale; Danish Saleheen; Juha Saltevo; Peter Eh Schwarz; Wayne H H Sheu; Harold Snieder; Timothy D Spector; Yasuharu Tabara; Jaakko Tuomilehto; Rob M van Dam; James G Wilson; James F Wilson; Bruce H R Wolffenbuttel; Tien Yin Wong; Jer-Yuarn Wu; Jian-Min Yuan; Alan B Zonderman; Nicole Soranzo; Xiuqing Guo; David J Roberts; Jose C Florez; Robert Sladek; Josée Dupuis; Andrew P Morris; E-Shyong Tai; Elizabeth Selvin; Jerome I Rotter; Claudia Langenberg; Inês Barroso; James B Meigs Journal: PLoS Med Date: 2017-09-12 Impact factor: 11.069
Authors: Kidola Jeremiah; Suzanne Filteau; Daniel Faurholt-Jepsen; Brenda Kitilya; Bazil B Kavishe; Rikke Krogh-Madsen; Mette F Olsen; John Changalucha; Andrea M Rehman; Nyagosya Range; Jerome Kamwela; Kaushik Ramaiya; Aase B Andersen; Henrik Friis; Douglas C Heimburger; George PrayGod Journal: PLoS One Date: 2020-04-08 Impact factor: 3.240
Authors: Francis Xavier Kasujja; Roy William Mayega; Meena Daivadanam; Elizabeth Ekirapa Kiracho; Ronald Kusolo; Fred Nuwaha Journal: PLoS One Date: 2022-08-04 Impact factor: 3.752
Authors: Belinda V Kweka; Cyprian Fredrick; Brenda Kitilya; Kidola Jeremiah; Eric Lyimo; Suzanne Filteau; Andrea M Rehman; Henrik Friis; Mette F Olsen; Daniel Faurholt-Jepsen; Rikke Krogh-Madsen; George PrayGod Journal: APMIS Date: 2022-03-01 Impact factor: 3.428